Indian pharmaceutical market (IPM) recorded a growth of 9.9% in value and 3.1% by volume in November, according to data released by market research firm Pharmarack.
After a weak performance in terms of volume growth for four months, November turned out to be a positive month for the sector, indicating a pickup in demand across key therapy areas in the acute and chronic segments, showed Pharmarack data.
«Cardiac, gastro, anti-diabetes and derma have shown robust growth above the IPM growth of 9.9%,» said Sheetal Sapale, vice-president-commercial at the research firm. «Except for a few, all the top therapies have shown positive volume growth… Unit growth for a few therapies also is encouraging,» she added.
Sales of antineoplastics, or cancer drugs, recorded the fastest growth in terms of volume at 11.8% in November. The dermatology and urology segments saw unit growth of 8.3% and 8.9%, respectively. «Price and new introductions are the more dominating growth drivers,» Sapale said.
Leadership
Business Storytelling Masterclass
By — Ameen Haque, Founder of Storywallahs
Finance
Tally Prime & GST Accounting: Complete Guide
By — CA Raj K Agrawal, Chartered Accountant
Marketing
Digital marketing — Wordpress Website Development
By — Shraddha Somani, Digital Marketing Trainer, Consultant, Strategiest and Subject Matter expert
Finance
Crypto & NFT Mastery: From Basics to Advanced
By — CA Raj K Agrawal, Chartered Accountant
Entrepreneurship
Boosting Startup Revenue with 6 AI-Powered Sales Automation Techniques
By — Dr. Anu